| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/04/2004 | CA2496489A1 Thermal gas flowmeter comprising a gas quality indicator |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2496464A1 Agent for prevention and/or treatment of itching |
| 03/04/2004 | CA2496429A1 Methods for diagnosing dementia-related neurological disorders |
| 03/04/2004 | CA2496321A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2496272A1 Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 03/04/2004 | CA2496251A1 High-throughput assay of hematopoietic stem and progenitor cell proliferation |
| 03/04/2004 | CA2496234A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | CA2496097A1 Keto cannabinoids with therapeutic indications |
| 03/04/2004 | CA2495798A1 Method of analyzing protein using laser ablation |
| 03/04/2004 | CA2495426A1 Programmable multiplexed active biologic array |
| 03/04/2004 | CA2495336A1 Use of lectin library for distinguishing glycoproteins or cells, diagnosing serum or cells, or fractionating glycoproteins or cells |
| 03/04/2004 | CA2495208A1 Preservation of rna quality and content in tissue sections during immunohistochemistry |
| 03/04/2004 | CA2494963A1 T-cell epitopes in erythropoietin |
| 03/04/2004 | CA2494806A1 Expression vectors encoding epitopes of target-associated antigens |
| 03/04/2004 | CA2494558A1 Method and kit for performing functional tests on biological cells immobilized on an array of scavenger molecules |
| 03/04/2004 | CA2491753A1 Method for determining gene knockout strategies |
| 03/04/2004 | CA2482031A1 Point source biological agent detection system |
| 03/03/2004 | EP1394551A2 Integrin as a predictor of endometriosis |
| 03/03/2004 | EP1394550A1 A method of analysing relative epitope appearance in a plurality of samples |
| 03/03/2004 | EP1394549A1 Biomarkers for diagnosing Alzheimer's disease |
| 03/03/2004 | EP1394548A2 Method for serotyping using type-specific antigens |
| 03/03/2004 | EP1394547A1 Chemical luminescence method using biochemical analysis units |
| 03/03/2004 | EP1394546A1 Method and system for determining the acceptability of signal data collected from a prothrombin time test strip |
| 03/03/2004 | EP1394545A1 Method of determining a haematocrit corrected glucose concentration in whole blood samples wherein the haematocrit concentration is measured by impedance spectroscopy |
| 03/03/2004 | EP1394543A1 Screening method |
| 03/03/2004 | EP1394542A1 Method of screening prion disease infection factor |
| 03/03/2004 | EP1394541A2 Ozone gas sensing element, detection apparatus, and measurement method |
| 03/03/2004 | EP1394535A1 Rapid response glucose sensor |
| 03/03/2004 | EP1394531A1 Handy internal quality inspection instrument |
| 03/03/2004 | EP1394274A2 Methods of testing for bronchial asthma or chronic obstructive pulmonary disease |
| 03/03/2004 | EP1394270A2 Molecular constructs and methods of use for detection of biochemical reactions |
| 03/03/2004 | EP1394267A1 Single nucleotide polymorphisms predictive for cardiovascular disease, adverse drug reactions, and drug efficacy |
| 03/03/2004 | EP1394263A1 Method of detecting and separating undifferentiated liver cellss using dlk |
| 03/03/2004 | EP1394256A2 HCV genomic sequences for diagnostics and therapeutics |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394250A1 Method of forming stable complex of transcription product of dna encoding arbitrary peptide with translation product, nucleic acid construct to be used in the method, complex formed by the method ; and screening of functional protein and mrna or dna encoding the protein using the method |
| 03/03/2004 | EP1394219A1 PH sensitive cyanine dyes as reactive fluorescent reagents |
| 03/03/2004 | EP1394182A1 Agents and methods for diagnosis and therapy of cancer and cancer risk assessment |
| 03/03/2004 | EP1394178A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 03/03/2004 | EP1393807A1 Testing device for examining a biological sample |
| 03/03/2004 | EP1393776A1 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 03/03/2004 | EP1393764A2 Integrated system including medication delivery pen, blood monitoring device, and lancer |
| 03/03/2004 | EP1393750A2 Conjugates for treating an immune disease |
| 03/03/2004 | EP1393742A1 Use of protein kinase N beta |
| 03/03/2004 | EP1393624A1 Knockin nonhuman animal producing human tissue factor |
| 03/03/2004 | EP1393623A1 Interstitial prostatism model animal |
| 03/03/2004 | EP1393441A1 Surface acoustic wave sensor |
| 03/03/2004 | EP1393329A2 Analytical device for test fluids, comprises a conductive polymer composition |
| 03/03/2004 | EP1393143A2 Portable flow cytometer |
| 03/03/2004 | EP1393136A1 Method for detecting and correcting sensor failure in oil and gas production system |
| 03/03/2004 | EP1393099A1 Estimation of toxic substance release |
| 03/03/2004 | EP1393078A1 Methods and kits for the in vitro diagnostic or for the monitoring of a disease involving an inflammatory reaction |
| 03/03/2004 | EP1393077A2 Method for identifying ligands for g protein coupled receptors |
| 03/03/2004 | EP1393076A2 Method for predicting the risk of transplant rejection and immunological testkit |
| 03/03/2004 | EP1393075A2 Methods of screening and using inhibitors of angiogenesis |
| 03/03/2004 | EP1393074A1 Compositions and methods for the detection of biomarkers associated with cardiovascular disease |
| 03/03/2004 | EP1393073A2 Methods for assembling protein microarrays |
| 03/03/2004 | EP1393072A1 Assay test system for regulating temperature |
| 03/03/2004 | EP1393071A2 Assay for predicting cell activity |
| 03/03/2004 | EP1393070A2 Diagnosis of metal allergy through cytokine release by t-cells in vitro |
| 03/03/2004 | EP1393069A1 Method and apparatus for detecting environmental smoke exposure |
| 03/03/2004 | EP1393068A2 Point-of-care in-vitro blood analysis system |
| 03/03/2004 | EP1393067A1 Encapsulated cell indicator system |
| 03/03/2004 | EP1393063A1 Automated flocculation titrimeter system |
| 03/03/2004 | EP1393054A1 Protonic conductive membrane gas sensor |
| 03/03/2004 | EP1393050A1 Method and apparatus for defining water content of a liquid. |
| 03/03/2004 | EP1393049A2 Toxicity monitor |
| 03/03/2004 | EP1393044A1 Method and device for determining the permeation of a barrier layer |
| 03/03/2004 | EP1393040A1 Measurement of radial modulus of elasticity of paper |
| 03/03/2004 | EP1393039A2 Mutation induced optimization of receptor signal to noise ratio |
| 03/03/2004 | EP1393038A2 A quantitative hybridization assay for the analysis of nucleic acid |
| 03/03/2004 | EP1392915A1 Rapid triglyceride assay for use in pulp pitch control |
| 03/03/2004 | EP1392872A2 Non-alloying core shell nanoparticles |
| 03/03/2004 | EP1392870A1 Screening for enzyme inhibitors |
| 03/03/2004 | EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 03/03/2004 | EP1392860A1 Molecular detection chip including mosfet, molecular detection device employing the chip, and molecular detection method using the device |
| 03/03/2004 | EP1392859A2 Isolating cells expressing secreted proteins |
| 03/03/2004 | EP1392855A2 Methods and compositions for the diagnosis and treatment of viral disease using 55092 |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392850A2 Method and system for identifying targets by nucleocytoplasmic cycling and use thereof |
| 03/03/2004 | EP1392849A2 Yeast screens for agents affecting protein folding |
| 03/03/2004 | EP1392848A2 Process for analyzing protein samples |
| 03/03/2004 | EP1392847A2 A high throughput assay for identification of gene expression modifiers |
| 03/03/2004 | EP1392845A2 A g-protein coupled receptor and uses therefor |
| 03/03/2004 | EP1392831A2 Moraxella(branhamella) catarrhalis antigens |
| 03/03/2004 | EP1392829A2 Compositions and methods relating to lung specific genes and proteins |
| 03/03/2004 | EP1392822A1 Double-transfected cell line useful for the identification of transport inhibitors |
| 03/03/2004 | EP1392820A1 Cyp450-specific dna probes and primers, and biological applications thereof |
| 03/03/2004 | EP1392817A2 Human secreted proteins |
| 03/03/2004 | EP1392803A2 Lubricant composition and analysis method for same |
| 03/03/2004 | EP1392776A2 Acridone derivatives as labels for fluorescence detection of target materials |
| 03/03/2004 | EP1392734A1 Hevein-binding monoclonal antibodies |
| 03/03/2004 | EP1392733A2 Mammalian tumor susceptibility gene products and their uses |
| 03/03/2004 | EP1392732A2 Method for apo ciii measurement in apob and non apob containing particles |
| 03/03/2004 | EP1392730A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent |
| 03/03/2004 | EP1392725A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology |
| 03/03/2004 | EP1392723A2 Medane genes and proteins |
| 03/03/2004 | EP1392719A2 Forms of prostate specific antigens and methods for their detection |
| 03/03/2004 | EP1392715A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |